Carbamazepine Screening, Urine
Carbamazepine is classified as an anticonvulsant drug and used to treat epileptic seizures. The class of drugs known as anticonvulsants are designed to help the physician in treating patients with seizures. The most common type of seizures that the physician encounters in clinical medicine are epileptic seizures. Basically a seizure is an abnormal, excessive firing of neurons in the gray matter of the brain. A seizure may cause violent, involuntary muscular contractions known as convulsions. Non-convulsive seizures can also occur in patients and these symptoms are defined as starring and very subtle musculature movements. Epilepsy is a disease of the brain in which an individual experiences recurrent seizures. Children may develop seizures as a result of a fever, known as febrile seizures.
The specific type of seizures that carbamazepine is used to treat are of the tonic-clonic, partial, and partial-complex seizures. Carbamazepine is metabolized to carbamazepine-10, 11-epoxide. One of the toxic side effects of this particular drug is aplastic anemia; consequently, it is recommended to order complete blood counts while the patient is taking this drug.
Overdose effects include shallow respiration, clammy skin, dilated pupils, weak and rapid pulse, coma, and possible death. Carbamazepine can be analyzed by a variety of analytical methods such as Gas Chromatography/Mass spectroscopy (GC/MS), Liquid Chromatography/Mass Spectroscopy (LC/MS), Immunoassay, and screening spot testing.
- Therapeutic monitoring
- Drug abuse evaluation
- Toxicity assessment
- Patient Compliance
Therapeutic level: 4-12 mg/L
Toxic level: >15 mg/L (or free carbamazepine >3mg/mL)
Note: therapeutic ranges and toxic thresholds are best evaluated from blood samples. Quantitative results obtained with blood samples collected at specific times after drug administration are preferred for pharmacokinetic analyses.
Cut-Off Ranges
Cut-off values can vary based on the particular method of analysis that is used for detection by a quantitative method, such as LC/MS or GC/MS. The testing laboratory cut-off range is listed on the patient report. Consult your physician for further information or click on one of the references that are listed below.
Urine specimen collected in a sterile container.
Stability
- Ambient: 3-5 days
- Refrigeration: 7-14 days
- Frozen: 30 days
- Baselt RC (ed). Disposition of toxic drugs and chemicals in man, 9th ed. Seal Beach, CA: Biomedical Publications; 2011.
- Baselt RC (ed). Analytical procedures for therapeutic drug monitoring and emergency toxicology, 2nd ed. Littleton, MA: PSG Publishing Co.; 1987.
- Baselt RC (ed). Disposition of toxic drugs and chemicals in man, 6th ed. Foster City, CA: Biomedical Publications; 2002.
- Gupta RN. Review: drug level monitoring: sedative hypnotics. J Chromatogr. 1985;340:139-72.
- Levine B (ed). Principles of Forensic Toxicology, 4th ed. Washington DC: AACC Press. Chapter 22, Anticonvulants and Antiarrhythmics, pp. 391-402; 2013.